Novo Nordisk has acquired Indiana-based Calibrium LLC and MB2 LLC, which are developing drugs for diabetes and metabolic diseases, some health insurers are dramatically increasing rates.
Drug developer Abbott Laboratories is poised to make a $25 billion bid for medical device maker St Jude Medical, allergy free parks could be a thing in the future.
Discover Houston's best orthopedic surgery centers and what features — from personalized treatment plans to rehabilitation services — make these top providers stand out in their industry.
Gene sequencing firm RainDance Technologies has withdrawn its $60M IPO, and researchers have found that omega-3 supplements might not have any affect on cognition for older people.
BioMarin Pharmaceutials is selling the global license for its PARP inhibitor talazoparibin to Medivation in a $570 million deal. Hatteras Venture Partners has raised $90 million as part of its first close for its fifth venture fund.
DaVita HealthCare Partners has acquired dialysis operator Renal Venture for $415 million.
Novartis has acquired the remaining rights to GlaxoSmithKline's multiple sclerosis drug Ofatumumab for up to $1 billion. Pfenex, a biotech working on an anthrax vaccine, has won a federal contract worth up to $143.5 million.
The layout of your phlebotomy station can significantly impact efficiency. A well-thought-out setup ensures that every tool is within reach, minimizing unnecessary movement and reducing patient wait times.
Valeant Pharmaceuticals is making a $1 billion pitch for Sprout Pharmaceuticals which received FDA approval for a women's libido enhancing drug.
CVS's MinuteClinic shows very high levels of patient satisfaction.
Illumina has partnered with Warburg Pincus and Sutter Hill Ventures to create digital hub Helix for consumers to obtain genetic tests and complementary services from third parties.
A study of high risk medical devices by Yale School of Medicine researchers found that the 1 percent of devices that are studied before getting FDA approval are not being studied enough.
Employees who enjoy their benefits are more inclined to stay with their company. A 2025 Marsh McLennan Agency report said 73% of employees would remain if plan options were better.
Former John's Hopkins neuroseorgion and GOP candidate Ben Carson has been vocal about criticizing Planned Parenthood, as it's currently under the microscope, but some of his previous research also involved the use of fetal tissue samples.
Roche has acquired in vitro diagnostics group GeneWEAVE BioSciences in a $425 million deal.
Helius Medical Technologies and the U.S. Army Medical Research and Materiel Command have announced a clinical trial for a traumatic brain injury device, and India is asking for $99.3M from Nestle after food scare involving Maggi noodles.
Google sees Alphabet holding company as a better way to organize and manage its healthcare and life science products, Gallup poll shows decline in uninsured rate.
Sanofi and Evotec have entered a collaboration to develop therapeutics to end or reduce the need for insulin injections for diabetes.